Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study

Donald Edgar Stull; Katherine Frances Stull; A Guminski; Donald Edgar Stull; Katherine Stull; R Gutzmer; MR Migden; L Dirix; KD Lewis; P Combemale; RM Herd; R Kudchadkar; U Trefzer; D Sellami; J Lear; R Dummer

Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study

Guminski, A., Stull, D., Houghton, K., Gutzmer, R., Migden, MR., Dirix, L., Lewis, KD., Combemale, P., Herd, RM., Kudchadkar, R., Trefzer, U., Sellami, D., Lear, J., & Dummer, R. (2016). Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study. Value in Health, 19(3), A159-A159. https://doi.org/10.1016/j.jval.2016.03.1474

Copy citation

Abstract

Differential change in fatigue in patients treated with sonidegib in BOLT correlated with geographic region, performance status, metastatic burden, and treatment response. Increase in fatigue was lower in patients responding to treatment. These data support the clinical benefit observed with sonidegib in patients with advanced BCC.